yr 〜
yr

Search results 10

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats. 8 10

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats. 8 10
Digital博士論文障害者向け資料あり
Kaya, Daisuke, Kaji, Kosuke, Tsuji, Yuki, Yamashita, Satoko, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiMDPI2019-09-26Cells
National Diet Library
  • Author Heading... Kitagawa, Koh Ozutsumi, Takahiro Fujinaga, Yukihisa Takaya, Hi...

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis. 8 6

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis. 8 6
Digital博士論文障害者向け資料あり
Tsuji, Yuki, Kaji, Kosuke, Kitade, Mitsuteru, Kaya, Daisuke, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Moriya, Kei, Akahane, Takemi, Yoshiji, HitoshiMDPI2020-06-19Microorganisms
National Diet Library
  • Author Heading... Kitagawa, Koh Ozutsumi, Takahiro Fujinaga, Yukihisa Takaya, Hi...

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. 21 15

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. 21 15
Digital博士論文障害者向け資料あり
Fujinaga, Yukihisa, Kawaratani, Hideto, Kaya, Daisuke, Tsuji, Yuki, Ozutsumi, Takahiro, Furukawa, Masanori, Kitagawa, Koh, Sato, Shinya, Nishimura, Norihisa, Sawada, Yasuhiko, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-08-04International journal of molecular sciences
National Diet Library
  • Author Heading...ke Tsuji, Yuki Ozutsumi, Takahiro Furukawa, Masanori Kitagawa, ...

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6
Digital博士論文障害者向け資料あり
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences
National Diet Library
  • Author HeadingOzutsumi, Takahiro Namisaki, Tadashi Shimozato, ...

Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model. 23 5

Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model. 23 5
Digital博士論文障害者向け資料あり
Kubo, Takuya, Kawaratani, Hideto, Sawada, Yasuhiko, Fujinaga, Yukihisa, Ozutsumi, Takahiro, Kaya, Daisuke, Tsuji, Yuki, Nakanishi, Keisuke, Furukawa, Masanori, Kitagawa, Kou, Saikawa, Soichiro, Sato, Shinya, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiBiomedical Research Network+2019-12Biomedical journal of scientific and technical research
National Diet Library
  • Author Heading...naga, Yukihisa Ozutsumi, Takahiro Kaya, Daisuke Tsuji, Yuki Nak...

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis.

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis.
Digital博士論文
Tsuji, Yuki, Kaji, Kosuke, Kitade, Mitsuteru, Kaya, Daisuke, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Moriya, Kei, Akahane, Takemi, Yoshiji, HitoshiMDPI2020-06-19Microorganisms8 6p.Article No.925-
Available onlineOther Libraries in Japan
  • Author Heading... Kitagawa, Koh Ozutsumi, Takahiro Fujinaga, Yukihisa Takaya, Hi...

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.
Digital博士論文
Fujinaga, Yukihisa, Kawaratani, Hideto, Kaya, Daisuke, Tsuji, Yuki, Ozutsumi, Takahiro, Furukawa, Masanori, Kitagawa, Koh, Sato, Shinya, Nishimura, Norihisa, Sawada, Yasuhiko, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-08-04International journal of molecular sciences21 15p.Article No.5589-
Available onlineOther Libraries in Japan
  • Author Heading...ke Tsuji, Yuki Ozutsumi, Takahiro Furukawa, Masanori Kitagawa, ...

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats.

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats.
Digital博士論文
Kaya, Daisuke, Kaji, Kosuke, Tsuji, Yuki, Yamashita, Satoko, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiMDPI2019-09-26Cells8 10p.Article No.1153-
Available onlineOther Libraries in Japan
  • Author Heading... Kitagawa, Koh Ozutsumi, Takahiro Fujinaga, Yukihisa Takaya, Hi...

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Digital博士論文
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences21 6p.Article No.2164-
Available onlineOther Libraries in Japan
  • Author HeadingOzutsumi, Takahiro Namisaki, Tadashi Shimozato, ...

Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model.

Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model.
Digital博士論文
Kubo, Takuya, Kawaratani, Hideto, Sawada, Yasuhiko, Fujinaga, Yukihisa, Ozutsumi, Takahiro, Kaya, Daisuke, Tsuji, Yuki, Nakanishi, Keisuke, Furukawa, Masanori, Kitagawa, Kou, Saikawa, Soichiro, Sato, Shinya, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiBiomedical Research Network+2019-12Biomedical journal of scientific and technical research23 5p.17787-17792
Available onlineOther Libraries in Japan
  • Author Heading...naga, Yukihisa Ozutsumi, Takahiro Kaya, Daisuke Tsuji, Yuki Nak...

Reached to the end of result.